Journal
CELL METABOLISM
Volume 7, Issue 6, Pages 496-507Publisher
CELL PRESS
DOI: 10.1016/j.cmet.2008.04.003
Keywords
-
Categories
Funding
- NHLBI NIH HHS [R01 HL076746-04, HL076746, R01 HL076746-05, R01 HL076746] Funding Source: Medline
- NIAID NIH HHS [T32 AI007290, AI066402, F31 AI066402] Funding Source: Medline
- NIDDK NIH HHS [R01 DK066525-07, R01 DK076760, DK076760, R01 DK076760-01A1, R01 DK066525] Funding Source: Medline
Ask authors/readers for more resources
Macrophage infiltration and activation in metabolic tissues underlie obesity-induced insulin resistance and type 2 diabetes. While inflammatory activation of resident hepatic macrophages potentiates insulin resistance, the functions of alternatively activated Kupffer cells in metabolic disease remain unknown. Here we show that in response to the Th2 cytokine interleukin-4 (IL-4), peroxisome proliferator-activated receptor delta (PPAR delta) directs expression of the alternative phenotype in Kupffer cells and adipose tissue macrophages of lean mice. However, adoptive transfer of PPAR delta(-/-) (Ppard(-/-)) bone marrow into wildtype mice diminishes alternative activation of hepatic macrophages, causing hepatic dysfunction and systemic insulin resistance. Suppression of hepatic oxidative metabolism is recapitulated by treatment of primary hepatocytes with conditioned medium from PPAR delta(-/-) macrophages, indicating direct involvement of Kupffer cells in liver lipid metabolism. Taken together, these data suggest an unexpected beneficial role for alternatively activated Kupffer cells in metabolic syndrome and type 2 diabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available